Cargando...
The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects
PURPOSE: Apixaban is often coadministered with treatments for cardiovascular comorbidities, which may lead to unintended drug–drug interactions (DDIs). The effects of apixaban on pharmacokinetics (PK) of multidose Lanoxin(®) (digoxin) and single-dose Tenormin(®) (atenolol) and the effects of single-...
Guardado en:
| Publicado en: | Clin Pharmacol |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5327911/ https://ncbi.nlm.nih.gov/pubmed/28260951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S115687 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|